Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 50, Issue 1, Pages 223-226Publisher
SPRINGER
DOI: 10.1007/s11239-020-02160-1
Keywords
SARS-CoV-2; COVID-19; Coagulation; Interstitial pneumonia; Pulmonary embolism; Case report
Ask authors/readers for more resources
Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available